受强制性开放获取政策约束的文章 - Nada Lallous了解详情
无法在其他位置公开访问的文章：3 篇
Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen Receptor
AC Naman Paul, Lavinia Arielle Carabet, Nada Lallous, Takeshi Yamazaki ...
Journal of Chemical Information and Modeling, 2016
强制性开放获取政策： US National Institutes of Health, Canadian Cancer Society
Development of 2-(5,6,7-Trifluoro-1H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor …
E Leblanc, F Ban, AD Cavga, S Lawn, CCF Huang, S Mohan, MEK Chang, ...
Journal of Medicinal Chemistry 64 (20), 14968-14982, 2021
强制性开放获取政策： US Department of Defense, Canadian Cancer Society, Canadian Institutes of …
Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness. Cancers 2022, 14, 5687
M Radaeva, CH Ho, N Xie, S Zhang, J Lee, L Liu, N Lallous, A Cherkasov, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
强制性开放获取政策： US Department of Defense, Canadian Institutes of Health Research
可在其他位置公开访问的文章：29 篇
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
N Lallous, SV Volik, S Awrey, E Leblanc, R Tse, J Murillo, K Singh, ...
Genome Biology 17 (10), 2016
强制性开放获取政策： US National Institutes of Health, Canadian Cancer Society, Canadian …
Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer
N Lallous, K Dalal, A Cherkasov, PS Rennie
International journal of molecular sciences 14 (6), 12496-12519, 2013
强制性开放获取政策： Canadian Institutes of Health Research, Genome Canada, Prostate Cancer Canada
Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer
RSN Munuganti, MDH Hassona, E Leblanc, K Frewin, K Singh, D Ma, ...
Chemistry & biology 21 (11), 1476-1485, 2014
强制性开放获取政策： Canadian Cancer Society, Canadian Institutes of Health Research, Prostate …
Structure, functional characterization, and evolution of the dihydroorotase domain of human CAD
A Grande-García, N Lallous, C Díaz-Tejada, S Ramón-Maiques
Structure 22 (2), 185-198, 2014
强制性开放获取政策： Government of Spain
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models
L Nappi, AH Aguda, N Al Nakouzi, B Lelj-Garolla, E Beraldi, N Lallous, ...
The Journal of clinical investigation 130 (2), 699-714, 2020
强制性开放获取政策： US Department of Energy, US National Institutes of Health, Canadian …
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression
F Zhang, M Biswas, S Massah, J Lee, S Lingadahalli, S Wong, C Wells, ...
Nucleic Acids Research 51 (1), 99-116, 2023
强制性开放获取政策： US Department of Defense, Canadian Institutes of Health Research, Natural …
An oncofetal glycosaminoglycan modification provides therapeutic access to cisplatin-resistant bladder cancer
R Seiler, HZ Oo, D Tortora, TM Clausen, CK Wang, G Kumar, MA Pereira, ...
European urology 72 (1), 142-150, 2017
强制性开放获取政策： Swiss National Science Foundation, Prostate Cancer Canada, Danish Council …
Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer
LA Carabet, N Lallous, E Leblanc, F Ban, H Morin, S Lawn, F Ghaidi, ...
European journal of medicinal chemistry 160, 108-119, 2018
强制性开放获取政策： Prostate Cancer Canada
The PHD finger of human UHRF1 reveals a new subgroup of unmethylated histone H3 tail readers
N Lallous, P Legrand, AG McEwen, S Ramón-Maiques, JP Samama, ...
PloS one 6 (11), e27599, 2011
强制性开放获取政策： National Institute of Health and Medical Research, France
Discovery of new catalytic topoisomerase II inhibitors for anticancer therapeutics
VM Matias-Barrios, M Radaeva, Y Song, Z Alperstein, AR Lee, V Schmitt, ...
Frontiers in oncology 10, 633142, 2021
强制性开放获取政策： Natural Sciences and Engineering Research Council of Canada
Computer-aided discovery of small molecules targeting the RNA splicing activity of hnRNP A1 in castration-resistant prostate cancer
LA Carabet, E Leblanc, N Lallous, H Morin, F Ghaidi, J Lee, PS Rennie, ...
Molecules 24 (4), 763, 2019
强制性开放获取政策： Prostate Cancer Canada
Bypassing drug resistance mechanisms of prostate cancer with small molecules that target androgen Receptor–Chromatin interactions
K Dalal, M Che, NS Que, A Sharma, R Yang, N Lallous, H Borgmann, ...
Molecular cancer therapeutics 16 (10), 2281-2291, 2017
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Canadian …
In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α
K Singh, RSN Munuganti, E Leblanc, YL Lin, E Leung, N Lallous, M Butler, ...
Breast Cancer Research 17, 1-17, 2015
强制性开放获取政策： Canadian Cancer Society
Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation
N Lallous, E Leblanc, RSN Munuganti, MDH Hassona, NA Nakouzi, ...
Molecular cancer therapeutics 15 (12), 2936-2945, 2016
强制性开放获取政策： US National Institutes of Health, Canadian Cancer Society, Canadian …
Development of an androgen receptor inhibitor targeting the N-Terminal domain of androgen receptor for treatment of castration resistant prostate cancer
F Ban, E Leblanc, AD Cavga, CCF Huang, MR Flory, F Zhang, ...
Cancers 13 (14), 3488, 2021
强制性开放获取政策： Canadian Institutes of Health Research
Development of novel inhibitors targeting the d-box of the dna binding domain of androgen receptor
M Radaeva, F Ban, F Zhang, E LeBlanc, N Lallous, PS Rennie, ...
International journal of molecular sciences 22 (5), 2493, 2021
强制性开放获取政策： Canadian Institutes of Health Research, Prostate Cancer Canada
Expression, purification, crystallization and preliminary X-ray diffraction analysis of the aspartate transcarbamoylase domain of human CAD
A Ruiz-Ramos, N Lallous, A Grande-García, S Ramón-Maiques
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2013
强制性开放获取政策： Government of Spain
出版信息和资助信息由计算机程序自动确定